Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2-primary breast cancer (BC) Meeting Abstract

  

Authors:	Elias, A. D.; Fournier, M.; Vidal, G. A.; Sams, S.; Spoelsta, N.; Kabos, P.; Diamond, J. R.; Shagisultanova, E.; Afghahi, A.; Mayordomo, J.; Wulfkuhle, J.; Petricoin, E.; Carter, L.; Zolman, K.; Armstead, S.; Winchester, A.; McSpadden, T.; Crawford, G.; Borges, V.; Gao, D. X.; Richer, J.
Abstract Title:	Phase II randomized trial of fulvestrant with or without enzalutamide in ER+/Her2-primary breast cancer (BC)
Meeting Title:	43rd Annual San Antonio Breast Cancer Symposium (2020 SABCS)
Journal Title:	Cancer Research
Volume:	81
Issue:	4 Suppl.
Meeting Dates:	2020 Dec 8-11
Meeting Location:	San Antonio, TX
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2021-02-01
Language:	English
ACCESSION:	WOS:000618737700379
PROVIDER:	wos
DOI:	10.1158/1538-7445.SABCS20-PS12-06
Notes:	Meeting Abstract: PS12-06 -- This symposium was held virtually due to COVID-19 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/179214